AUSTIN, Texas, Nov. 5, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2020. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”). CURRENT FINANCIAL HIGHLIGHTS Total revenue for the third quarter of $106.1M, a 35% increase over Q3 2019, driven... Read more
AUSTIN, Texas, Oct. 22, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020. A press release announcing the results is scheduled for release after the close of trading on that date. Management will hold a conference... Read more
AUSTIN, Texas, Oct. 7, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced 3rd quarter 2020 revenues of approximately $106 million, up approximately 35% over the 3rd quarter of 2019. Highlights include: Molecular Diagnostics revenue of approximately $60 million, up almost 100% vs. Q3 2019 Licensed Technologies Group revenue of approximately $35 million, down 10% vs.... Read more
AUSTIN, Texas, Sept. 24, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received a $5,389,813 award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, to conduct product development work and complete... Read more
AUSTIN, Texas, Sept. 23, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received an award of $683,500 from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, to support the enhancement of... Read more
AUSTIN, Texas, Sept. 15, 2020 /PRNewswire/ — On September 10, 2020, Luminex Corporation (Nasdaq:LMNX) (the “Company”), announced that its board of directors declared a cash dividend for the third quarter of 2020 of $0.09 per share of common stock payable on October 15, 2020 to stockholders of record as of the close of business September 24, 2020. About Luminex... Read more
AUSTIN, Texas, Aug. 4, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced the retirement of its Chairman, G. Walter Loewenbaum, from its Board of Directors (“Board”) effective August 3, 2020. “On behalf of Luminex’s shareholders and Board, I would like to thank Wally for his invaluable service and contributions to Luminex for over 25... Read more
Delivers Accelerated Organic Growth and Profitability AUSTIN, Texas, Aug. 4, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its second quarter ended June 30, 2020. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”). CURRENT FINANCIAL HIGHLIGHTS Total revenue for the second quarter of $109.5M, a 32%... Read more
AUSTIN, Texas, July 22, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted an EUA request to the FDA for a new expanded version of its NxTAG® Respiratory Pathogen Panel (RPP) to include the SARS-CoV-2 virus for high-throughput COVID-19 testing. The new test is a combination of the company’s original NxTAG RPP,... Read more
AUSTIN, Texas, July 20, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the second quarter ended June 30, 2020 on Tuesday, August 4, 2020. A press release announcing the results is scheduled for release after the close of trading on that date. Management will hold a conference... Read more